Search - tctmd.com

Displaying 121 - 140 of 496

Sort: Relevancy | Date

Presentation TCT 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

TAVR in Heart Failure: UNLOAD

Presenter: James E. Udelson, Clyde W. Yancy, Ori Ben-Yehuda

September 22, 2018

Presentation TCT 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen

September 22, 2018

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Presenter: Philippe Pibarot

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

Presentation TCT 2018

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Presentation TCT 2018

NO The Data are Inconclusive and the Costs are Prohibitive!

Presenter: John K. Forrest

September 22, 2018

Presentation TCT 2018

YES Review of ALL the Data and Common Sense Tell the Story!

Presenter: Susheel K. Kodali

September 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

Cedars-Sinai Medical Center (USA

Presenter: Tarun Chakravarty

September 22, 2018

Presentation TCT 2018

Erasmus University (The Netherlands)

Presenter: Herbert Kroon

September 22, 2018

Presentation TCT 2018

Ulm University (Germany)

Presenter: Jochen Wöhrle

September 22, 2018

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

TAVR Outcomes for BAV in Asian Patients

Presenter: Joseph E. Bavaria, Horst Sievert, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

Device Selection and CT Sizing for TAVR Treatment of BAV

Presenter: Joseph E. Bavaria, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Presenter: Joseph E. Bavaria, Horst Sievert, Hasan Jilaihawi

September 22, 2018

Advertisement

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

TAVR in Heart Failure: UNLOAD

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

NO The Data are Inconclusive and the Costs are Prohibitive!

YES Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA

Erasmus University (The Netherlands)

Ulm University (Germany)

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

TAVR Outcomes for BAV in Asian Patients

Device Selection and CT Sizing for TAVR Treatment of BAV

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content